Literature DB >> 3219483

The dihydropyridine derivative 202-791: interpretation of the effects of the racemate considering inverse agonistic enantiomers.

M Damarowsky1, H Lüllmann, U Ravens.   

Abstract

1. The influence of the enantiomers and the racemate of the dihydropyridine derivative 202-791 [isopropyl 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-3- pyridinecarboxylate] on force of contraction and action potential was studied in guinea-pig isolated papillary muscles. The effects were investigated during regular stimulation (1 Hz) and after a period of rest (10 min). 2. The enantiomers of the dihydropyridine derivative 202-791 had opposite effects on the mechanical and bioelectrical parameters: the (+,S)-enantiomer enhanced contractility and prolonged action potential duration whereas the (-,R)-enantiomer reduced force and shortened action potential duration. Analogous to the effects during regular stimulation, the post-rest adaptation was modified adversely: in the presence of the (+,S)-enantiomer the pattern of adaptation was intensified while the (-,R)-enantiomer caused an attenuation. The term 'inverse agonism' seems more suitable than the commonly used comparison of agonist and antagonist, because each enantiomer possesses intrinsic activity, albeit in opposite directions. 3. The racemate of 202-791 acted like the (+,S)-enantiomer. In concentrations up to 1 microM, the racemate increased the force of contraction to the same extent as if the cardiodepressant (-,R)-enantiomer was not present. Only at the highest concentration (3 microM) did the counteracting effect of the (-,R)-enantiomer become evident. The racemate prolonged the action potential duration like the (+,S)-enantiomer although to a lesser extent. Moreover, the typical post-rest adaptation of contractile force and action potential duration was accentuated by the racemate as with the (+,S)-enantiomer. 4. The results demonstrate that in case of 202-791, the effects of the racemate do not reflect the opposite actions of the two enantiomers, but rather mimic that of the (+,S)-enantiomer. A prediction concerning the effects of the enantiomers which is based on findings obtained with the racemate is not possible.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219483      PMCID: PMC1854259          DOI: 10.1111/j.1476-5381.1988.tb11747.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists.

Authors:  M C Sanguinetti; R S Kass
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

2.  Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.

Authors:  G Thomas; R Gross; M Schramm
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

3.  Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent.

Authors:  M C Sanguinetti; R S Kass
Journal:  J Mol Cell Cardiol       Date:  1984-07       Impact factor: 5.000

4.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

5.  Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels.

Authors:  M Schramm; G Thomas; R Towart; G Franckowiak
Journal:  Nature       Date:  1983 Jun 9-15       Impact factor: 49.962

6.  Effects of dihydropyridine calcium channel modulators in the heart: pharmacological and radioligand binding correlations.

Authors:  A Schwartz; I L Grupp; G Grupp; J S Williams; P L Vaghy
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

7.  Studies on the mechanism of action of the vasoconstrictive dihydropyridine, CGP 28392.

Authors:  R Loutzenhiser; U T Rüegg; A Hof; R P Hof
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

8.  Stereoselectivity at the calcium channel: opposite action of the enantiomers of a 1,4-dihydropyridine.

Authors:  R P Hof; U T Rüegg; A Hof; A Vogel
Journal:  J Cardiovasc Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.105

9.  Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.

Authors:  B P Bean
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

10.  Binding properties of a novel calcium channel activating dihydropyridine in monolayer cultures of beating myocytes.

Authors:  P Bellemann
Journal:  FEBS Lett       Date:  1984-02-13       Impact factor: 4.124

View more
  1 in total

1.  Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles.

Authors:  U Ravens; H P Schöpper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.